サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1300809

アレルギー診断薬と治療薬の世界市場規模調査＆予測：製品別、アレルゲンタイプ別、検査タイプ別、薬剤クラス別、地域別分析、2023-2030年

Global Allergy diagnostics and therapeutics Market Size study & Forecast, by Product by Allergen Type, by Test Type, by Drug Class and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
アレルギー診断薬と治療薬の世界市場規模調査＆予測：製品別、アレルゲンタイプ別、検査タイプ別、薬剤クラス別、地域別分析、2023-2030年
出版日: 2023年06月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アレルギー診断薬と治療薬の世界市場は、2022年に約293億6,000万米ドルと評価され、予測期間2023-2030年には6.6%以上の堅調な成長率で成長すると予測されています。

アレルギー診断薬と治療薬は、アレルギーの特定と治療に焦点を当てた医学・ヘルスケア分野を指します。アレルギーは、花粉、ダニ、特定の食物、動物のフケなど、アレルゲンとして知られる無害な物質に対して免疫系が過剰に反応することで発症します。アレルギー診断薬と治療薬市場は、アレルギーの罹患率の上昇や技術の進歩、新製品の発売などの要因により拡大しています。

American College of Allergy, Asthma &Immunologyによると、毎年5,000万人以上のアメリカ人がアレルギーに悩まされています。また、statistaによると、インドでは、アレルギーに苦しむ人の数は、インド全土で2018年の13％から2020年には15％に増加しています。これと同様に、アメリカ喘息・アレルギー財団のデータによると、2021年には8,100万人のアメリカ人が季節性アレルギー性鼻炎と診断され、成人の約26％、子供の約19％が罹患しています。このように、地域全体でアレルギーの罹患率が上昇していることが、市場の成長を促進しています。また、免疫療法薬の高い普及率と環境汚染物質への曝露の増加が、市場成長に有利な機会を生み出しています。しかし、技術コストが高く、アレルゲンが標準化されていないため、新興諸国での採用や普及が低く、2023-2030年の予測期間を通じて市場成長を阻害しています。

アレルギー診断薬および治療薬の世界市場調査において考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、ブランド製品の優位性と地域の疾患有病率の増加により、2022年の市場を独占しました。アジア太平洋地域は、対象人口の増加、製品開発のための提携の増加、主要企業の地理的拡大などの要因により、予測期間中に大きく成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別・市場推計・予測、2020-2030年
    • アレルギー診断薬と治療薬市場：地域別、2020-2030年
    • アレルギー診断薬と治療薬市場：製品別、2020-2030年
    • アレルギー診断薬と治療薬市場：アレルゲンタイプ別、2020-2030年
    • アレルギー診断薬と治療薬市場：検査タイプ別、2020～2030年
    • アレルギー診断薬と治療薬市場：薬剤クラス別、2020～2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 アレルギー診断薬と治療薬の世界市場定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 アレルギー診断薬と治療薬の世界市場力学

  • アレルギー診断薬と治療薬市場の影響分析（2020-2030年）
    • 市場促進要因
      • アレルギー発症率の増加
      • 技術の進歩と新製品の発売
    • 市場の課題
      • 技術コストが高いため、新興諸国での普及率が低い
      • アレルゲン標準化の欠如
    • 市場機会
      • 免疫療法薬の高い普及率
      • 環境汚染物質への曝露の増加

第4章 アレルギー診断薬と治療薬の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 アレルギー診断薬と治療薬の世界市場：製品別

  • 市場スナップショット
  • アレルギー診断薬と治療薬の世界市場：製品別、実績- ポテンシャル分析
  • アレルギー診断薬と治療薬の世界市場：製品別、推定・予測、2020-2030年
  • アレルギー診断薬と治療薬市場、サブセグメント分析
    • 機器
    • 消耗品
    • サービス

第6章 アレルギー診断薬と治療薬の世界市場：アレルゲンタイプ別

  • 市場スナップショット
  • アレルギー診断薬と治療薬の世界市場：アレルゲンタイプ別、実績- ポテンシャル分析
  • アレルギー診断薬と治療薬の世界市場：アレルゲンタイプ別、推定・予測、2020-2030年
  • アレルギー診断薬と治療薬市場、サブセグメント分析
    • 食品
    • 吸入薬
    • 薬剤
    • その他

第7章 アレルギー診断薬と治療薬の世界市場：検査タイプ別

  • 市場スナップショット
  • アレルギー診断薬と治療薬の世界市場：検査タイプ別、実績- ポテンシャル分析
  • アレルギー診断薬と治療薬の世界市場：検査タイプ別、推定・予測、2020～2030年
  • アレルギー診断薬と治療薬市場、サブセグメント分析
    • 生体内検査
    • 試験管内検査

第8章 アレルギー診断薬と治療薬の世界市場：薬剤クラス別

  • 市場スナップショット
  • アレルギー診断薬と治療薬の世界市場：薬物クラス別、実績- ポテンシャル分析
  • アレルギー診断薬と治療薬の世界市場：薬効クラス別、推定・予測、2020～2030年
  • アレルギー診断薬と治療薬市場、サブセグメント分析
    • 抗ヒスタミン薬
    • うっ血除去薬
    • 副腎皮質ステロイド薬
    • 肥満細胞安定剤
    • ロイコトリエン阻害薬
    • 経鼻抗コリン薬
    • その他

第9章 アレルギー診断薬と治療薬の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • アレルギー診断薬と治療薬市場、市場スナップショット、地域別
  • 北米
    • 米国
      • 製品の推定・予測、2020-2030年
      • アレルゲンタイプの推定・予測、2020-2030年
      • 検査タイプの推定・予測、2020～2030年
      • 薬剤クラス別の推定・予測、2020-2030年
    • カナダ
  • 欧州のアレルギー診断薬と治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のアレルギー診断薬と治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのアレルギー診断薬と治療薬市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第10章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • R-Biopharm AG
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • EUROIMMUN Medizinische Labordiagnostika AG
    • DASIT Group SPA
    • AESKU.GROUP GmbH
    • bioMerieux SPA
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc
    • Stallergenes Greer
    • Minaris Medical America, Inc.
    • Siemens Healthcare GmbH

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Allergy diagnostics and therapeutics Market, report scope
  • TABLE 2. Global Allergy diagnostics and therapeutics Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Allergy diagnostics and therapeutics Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Allergy diagnostics and therapeutics Market estimates & forecasts by Allergen Type 2020-2030 (USD Billion)
  • TABLE 5. Global Allergy diagnostics and therapeutics Market estimates & forecasts by Test type 2020-2030 (USD Billion)
  • TABLE 6. Global Allergy diagnostics and therapeutics Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
  • TABLE 7. Global Allergy diagnostics and therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Allergy diagnostics and therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Allergy diagnostics and therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Allergy diagnostics and therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Allergy diagnostics and therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Allergy diagnostics and therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Allergy diagnostics and therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Allergy diagnostics and therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Allergy diagnostics and therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Allergy diagnostics and therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. U.S. Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21. Canada Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. Canada Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24. UK Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. UK Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27. Germany Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. Germany Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30. France Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. France Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33. Italy Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Italy Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36. Spain Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. Spain Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39. RoE Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. RoE Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42. China Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. China Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45. India Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. India Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48. Japan Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. Japan Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51. South Korea Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. South Korea Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54. Australia Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. Australia Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60. Brazil Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Brazil Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63. Mexico Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. Mexico Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66. RoLA Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. RoLA Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. Saudi Arabia Allergy diagnostics and therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 69. South Africa Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. RoMEA Allergy diagnostics and therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Allergy diagnostics and therapeutics Market
  • TABLE 72. List of primary sources, used in the study of global Allergy diagnostics and therapeutics Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Allergy diagnostics and therapeutics Market, research methodology
  • FIG 2. Global Allergy diagnostics and therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Allergy diagnostics and therapeutics Market, key trends 2022
  • FIG 5. Global Allergy diagnostics and therapeutics Market, growth prospects 2023-2030
  • FIG 6. Global Allergy diagnostics and therapeutics Market, porters 5 force model
  • FIG 7. Global Allergy diagnostics and therapeutics Market, pest analysis
  • FIG 8. Global Allergy diagnostics and therapeutics Market, value chain analysis
  • FIG 9. Global Allergy diagnostics and therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Allergy diagnostics and therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Allergy diagnostics and therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Allergy diagnostics and therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Allergy diagnostics and therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Allergy diagnostics and therapeutics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Allergy diagnostics and therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Allergy diagnostics and therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Allergy diagnostics and therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Allergy diagnostics and therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Allergy diagnostics and therapeutics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Allergy diagnostics and therapeutics Market is valued approximately USD 29.36 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.6% over the forecast period 2023-2030. Allergy diagnostics and therapeutics refer to the field of medicine and healthcare focused on identifying and treating allergies. Allergies occur when the immune system overreacts to harmless substances known as allergens, such as pollen, dust mites, certain foods, or animal dander. The Allergy diagnostics and therapeutics market is expanding because of factors such as rising increasing incidence of allergies and advancements in technology and launch of new products.

According to Information form the American College of Allergy, Asthma & Immunology, More than 50 million Americans suffer from allergies each year. In addition, according to statista, in India The number of people suffering from allergies had increased from 13% in 2018 to 15% in 2020 across India. Similar to this, according to data from the Asthma and Allergy Foundation of America, 81 million Americans were diagnosed with seasonal allergic rhinitis in 2021, making up about 26% of adults and 19% of children who were affected. Thus rising incidence of allergies across the regions is driving the market growth. In addition, high adoption of immunotherapy drugs and rising exposure to environmental pollutants is creating a lucrative opportunity to the market growth. However, low adoption and penetration in developing countries due to the high cost of technology and lack of allergen standardization stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Allergy diagnostics and therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for product development, geographic expansion of key players.

Major market players included in this report are:

  • R-Biopharm AG
  • EUROIMMUN Medizinische Labordiagnostika AG
  • DASIT Group SPA
  • AESKU.GROUP GmbH
  • bioMerieux SPA
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc
  • Stallergenes Greer
  • Minaris Medical America, Inc.
  • Siemens Healthcare GmbH

Recent Developments in the Market:

  • In May 2021, Glenmark announced the launched of nasal spray name Ryaltris, the product can be used to treat the moderate to severe allergic rhinitis.
  • In June 2022, -Oncologica, has launched a new Allergyfocus test which helps the sufferers discover common allergens their bodies react to. Antibodies that have been produced in response to a certain allergen are found by allergyfocus. The antibody allergy test saves allergy patients from making numerous trips to allergy specialists as well as the trial and error method of determining the source of their allergic reactions.

Global Allergy diagnostics and therapeutics Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Allergen Type, Test Type, Drug Class, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Instruments
  • Consumables
  • Services

By Allergen Type:

  • Food
  • Inhaled
  • Drugs
  • Others

By Test type:

  • In Vivo test
  • In vitro test

By Drug Class:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anti-cholinergic
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Allergy diagnostics and therapeutics Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Allergy diagnostics and therapeutics Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Allergy diagnostics and therapeutics Market, by Allergen Type, 2020-2030 (USD Billion)
    • 1.2.4. Allergy diagnostics and therapeutics Market, by Test type, 2020-2030 (USD Billion)
    • 1.2.5. Allergy diagnostics and therapeutics Market, by Drug Class, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Allergy diagnostics and therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Allergy diagnostics and therapeutics Market Dynamics

  • 3.1. Allergy diagnostics and therapeutics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of allergies
      • 3.1.1.2. Advancements in technology and launch of new products
    • 3.1.2. Market Challenges
      • 3.1.2.1. Low adoption and penetration in developing countries due to the high cost of technology
      • 3.1.2.2. Lack of allergen standardization
    • 3.1.3. Market Opportunities
      • 3.1.3.1. High adoption of immunotherapy drugs
      • 3.1.3.2. Rising exposure to environmental pollutants

Chapter 4. Global Allergy diagnostics and therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Allergy diagnostics and therapeutics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Allergy diagnostics and therapeutics Market by Product, Performance - Potential Analysis
  • 5.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
    • 5.4.1. Instruments
    • 5.4.2. Consumables
    • 5.4.3. Services

Chapter 6. Global Allergy diagnostics and therapeutics Market, by Allergen Type

  • 6.1. Market Snapshot
  • 6.2. Global Allergy diagnostics and therapeutics Market by Allergen Type, Performance - Potential Analysis
  • 6.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Allergen Type 2020-2030 (USD Billion)
  • 6.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
    • 6.4.1. Food
    • 6.4.2. Inhaled
    • 6.4.3. Drugs
    • 6.4.4. Others

Chapter 7. Global Allergy diagnostics and therapeutics Market, by Test type

  • 7.1. Market Snapshot
  • 7.2. Global Allergy diagnostics and therapeutics Market by Test type, Performance - Potential Analysis
  • 7.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Test type 2020-2030 (USD Billion)
  • 7.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
    • 7.4.1. In Vivo test
    • 7.4.2. In vitro test

Chapter 8. Global Allergy diagnostics and therapeutics Market, by Drug Class

  • 8.1. Market Snapshot
  • 8.2. Global Allergy diagnostics and therapeutics Market by Drug Class, Performance - Potential Analysis
  • 8.3. Global Allergy diagnostics and therapeutics Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
  • 8.4. Allergy diagnostics and therapeutics Market, Sub Segment Analysis
    • 8.4.1. Antihistamines
    • 8.4.2. Decongestants
    • 8.4.3. Corticosteroids
    • 8.4.4. Mast Cell Stabilizers
    • 8.4.5. Leukotriene Inhibitors
    • 8.4.6. Nasal Anti-cholinergic
    • 8.4.7. Others

Chapter 9. Global Allergy diagnostics and therapeutics Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Allergy diagnostics and therapeutics Market, Regional Market Snapshot
  • 9.4. North America Allergy diagnostics and therapeutics Market
    • 9.4.1. U.S. Allergy diagnostics and therapeutics Market
      • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Allergen Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Test type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. Drug Class breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Allergy diagnostics and therapeutics Market
  • 9.5. Europe Allergy diagnostics and therapeutics Market Snapshot
    • 9.5.1. U.K. Allergy diagnostics and therapeutics Market
    • 9.5.2. Germany Allergy diagnostics and therapeutics Market
    • 9.5.3. France Allergy diagnostics and therapeutics Market
    • 9.5.4. Spain Allergy diagnostics and therapeutics Market
    • 9.5.5. Italy Allergy diagnostics and therapeutics Market
    • 9.5.6. Rest of Europe Allergy diagnostics and therapeutics Market
  • 9.6. Asia-Pacific Allergy diagnostics and therapeutics Market Snapshot
    • 9.6.1. China Allergy diagnostics and therapeutics Market
    • 9.6.2. India Allergy diagnostics and therapeutics Market
    • 9.6.3. Japan Allergy diagnostics and therapeutics Market
    • 9.6.4. Australia Allergy diagnostics and therapeutics Market
    • 9.6.5. South Korea Allergy diagnostics and therapeutics Market
    • 9.6.6. Rest of Asia Pacific Allergy diagnostics and therapeutics Market
  • 9.7. Latin America Allergy diagnostics and therapeutics Market Snapshot
    • 9.7.1. Brazil Allergy diagnostics and therapeutics Market
    • 9.7.2. Mexico Allergy diagnostics and therapeutics Market
  • 9.8. Middle East & Africa Allergy diagnostics and therapeutics Market
    • 9.8.1. Saudi Arabia Allergy diagnostics and therapeutics Market
    • 9.8.2. South Africa Allergy diagnostics and therapeutics Market
    • 9.8.3. Rest of Middle East & Africa Allergy diagnostics and therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. R-Biopharm AG
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. EUROIMMUN Medizinische Labordiagnostika AG
    • 10.3.3. DASIT Group SPA
    • 10.3.4. AESKU.GROUP GmbH
    • 10.3.5. bioMerieux SPA
    • 10.3.6. Danaher Corporation
    • 10.3.7. Thermo Fisher Scientific, Inc
    • 10.3.8. Stallergenes Greer
    • 10.3.9. Minaris Medical America, Inc.
    • 10.3.10. Siemens Healthcare GmbH

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption